SecBot SecBot

VINC

Vincerx Pharma, Inc.
Pharmaceutical Preparations· CIK 0001796129 Biotech & Drug Discovery
$0.0150 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $0.0150
1 year
−53.1%
from $0.0320 · Oct 27
30 days
0.0%
from $0.0150
52-week range
$0.005000–0.0320
−53% from high · low Oct 30
Avg volume 20D
750
Oct 9 spike 11.0K
Short interest
🔒 Subscribers only
New fund stakes
0
Q4 2024 13F · 0 exits

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q4 2024: 2 added (0 new), 4 trimmed or exited.

  • TrendRANGE

    3% below its 50-day average.

Who's buying

13F· Q4 2024
0
new positions
0
exits
FundMoveSharesValue
VANGUARD GROUP INCTRIM286,372$75.3K
UBS Group AGDOUBLED92,779$24.4K
HRT FINANCIAL LPDOUBLED59,804$15.0K
RENAISSANCE TECHNOLOGIES LLCTRIM22,100$5.8K
JANE STREET GROUP, LLCTRIM11,190$2.9K
JPMORGAN CHASE & COTRIM23$6.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Oct 2024
Recent actions
DateFirmActionRating
Oct 8, 2024Leerink Partners
MAINTAIN
MAINTAINOutperform
Apr 9, 2024Cantor Fitzgerald
REITERATE
REITERATEOverweight
Apr 1, 2024Cantor Fitzgerald
REITERATE
REITERATEOverweight
Sep 7, 2023Cantor Fitzgerald
REITERATE
REITERATEOverweight
Nov 17, 2022Chardan Capital
MAINTAIN
MAINTAINBuy
Aug 12, 2022SVB Leerink
MAINTAIN
MAINTAINOutperform

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
May 13, 2026 Earnings calendar
VINC Q1 2026 Earnings Scheduled — 2026-05-13
Dec 31, 2024 Inst.
VANGUARD GROUP INC — TRIM
286,372 shares ($75.3K)
Dec 31, 2024 Inst.
UBS Group AG — DOUBLED
92,779 shares ($24.4K)